Page 19 - Service Testing News Today

By Chris Wack BiomX said it saw positive safety and efficacy results from the second part of its Phase 1b/2a trial evaluating its novel phage cocktail,...

By Colin Kellaher AbbVie said Wednesday that a Phase 2 study of its experimental drug telisotuzumab-vedotin, or teliso-V, showed a reduction in disease in...

It's the latest indication that Mounjaro is more effective than Ozempic for weight loss.

Xenon Pharmaceuticals shares fell early Monday after the company released new clinical-trial data on an experimental depression treatment

By Dean Seal Shares of Xenon Pharmaceuticals rose Monday after the company disclosed results from a clinical trial of XEN1101, its experimental treatment for...

By Ben Glickman Shares of Acelyrin fell on Monday after the company said there was a programming error in its drug trial of a treatment for psoriatic...

By Denny Jacob American depositary receipts of Alterity Therapeutics dived 31% to $1.64 following the raising of capital to provide ongoing funding to...

By Colin Kellaher Entrada Therapeutics shares slid on Wednesday after the biopharmaceutical company said the Food and Drug Administration wouldn't lift the...

Company halts study for blood-thinning drug, is told to pay $1.56 billion in lawsuit relating to weedkiller

By Chris Wack Landos Biopharma shares were up 10% to $4.31 after the company published positive safety, tolerability, pharmacokinetic and clinical efficacy...